Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes
Get Live Data
5.75    -0.10 (-1.71%)
Bid:
5.70
Ask:
5.80
Spread: 0.10 (1.754%)
Market Cap: £61.50m
STX Live PriceLast checked at - London Stock Exchange

Intraday Shield Thera Share Chart

Shield Thera News

TRADING UPDATES: Shield closer to Canada approval; Angle plans raise
14 Jul 2022

TRADING UPDATES: Shield closer to Canada approval; Angle plans raise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

EARNINGS UPDATES: Kingswood revenue surges; Shield in loan deal
30 Jun 2022

EARNINGS UPDATES: Kingswood revenue surges; Shield in loan deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

TRADING UPDATES: Further progress at Blencowe and Rockfire mines
21 Mar 2022

TRADING UPDATES: Further progress at Blencowe and Rockfire mines

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Shield's Canadian partner files new drug submission for Accrufer
21 Mar 2022

Shield's Canadian partner files new drug submission for Accrufer

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that KYE Pharmaceuticals has submitted a new drug s...

Shield Therapeutics revenue falls in line with expectations
17 Feb 2022

Shield Therapeutics revenue falls in line with expectations

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported total 2021 revenue of £1.5m in a trading update on Thursd...

Shield Therapeutics shares fall as guides for sharp 2021 revenue drop
17 Feb 2022

Shield Therapeutics shares fall as guides for sharp 2021 revenue drop

(Alliance News) - Shield Therapeutics PLC's shares tumbled on Thursday after a trading update revealed a substantial, but expected, fall in revenue.

Shield Therapeutics enters Accrufer licensing deal in Canada
5 Jan 2022

Shield Therapeutics enters Accrufer licensing deal in Canada

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it anno...